Top Markets
#1 Ontology Gas Ontology Gas +30.80%
#2 EXOD EXOD +22.08%
#3 Status Status +21.90%
#4 ETHGas ETHGas +19.74%
#5 The Black Bull The Black Bull +17.98%
#6 Anvil Anvil +12.83%
#7 Fake World Assets Fake World Assets +10.94%
#8 aelf aelf +9.61%
#9 Gas Gas +9.27%
#10 Derive Derive +8.79%
Coin of the day
Ontology Gas Ontology Gas
Settings
Language
ENGLISH
Currency
USD
Theme
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Rank in Stocks #25523
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Share Price
$9.81
Last synced: 2025-03-18
Market Cap
$48.68M
Change (1 day)
1.55%
Change (1 year)
0.00%
Country
US
Trade AlloVir, Inc. (ALVR)

Category

Healthcare
Number of shares outstanding for AlloVir, Inc. (ALVR)
Number of shares outstanding as of June 2026: 23.80M
According to AlloVir, Inc. latest financial reports and stock price the company's current number of shares outstanding is 23.80M. At the end of December 2023 the company had 4.47M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for AlloVir, Inc. (ALVR) from 2018 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 23.80M 379.57%
2024 4.96M 10.90%
2023 4.47M 35.75%
2022 3.30M 22.10%
2021 2.70M 133.42%
2020 1.16M -36.07%
2019 1.81M 38.40%
2018 1.31M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 966.93%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 161.31%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 1,932.06%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 1,564.05%
US